---
title: "Matinas BioPharma Holdings, Inc. (MTNB.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/MTNB.US.md"
symbol: "MTNB.US"
name: "Matinas BioPharma Holdings, Inc."
industry: "Biotechnology"
---

# Matinas BioPharma Holdings, Inc. (MTNB.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.matinasbiopharma.com](https://www.matinasbiopharma.com) |

## Company Profile

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company’s LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.23 | 101/604 | - | - | - |
| PB | 0.63 | 49/604 | 1.16 | 0.72 | 0.43 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-04-30T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 1 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.61 |

## References

- [Company Overview](https://longbridge.com/en/quote/MTNB.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/MTNB.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/MTNB.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
